Genflow Biosciences plc (LON:GENF)
London flag London · Delayed Price · Currency is GBP · Price in GBX
1.850
+0.050 (2.75%)
Oct 15, 2026, 4:01 PM GMT

Genflow Biosciences Financials Overview

Millions GBP. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.590.590.320.17--
Revenue Growth
0%82.73%88.67%---
Gross Profit
0.590.590.320.17--
Operating Income
-1.1-1.42-1.59-1.86-1.33-1.08
Net Income
-1.1-1.42-1.59-1.86-1.34-1.08
Earnings Per Share
-0.00-0.00-0.00-0.01-0.00-0.01
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
0.630.110.280.682.360.22
Net Cash Growth
465.83%-59.88%-59.26%-70.97%951.87%-11.89%
Net Cash Per Share
0.000.000.000.000.010.00
Cash & Investments
0.630.110.280.682.360.22

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-1.23-1.44-1.08-1.66-1.37-0.82
Capital Expenditures
-0---0-0-
Free Cash Flow
-1.23-1.44-1.08-1.66-1.37-0.82
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%--
Operating Margin
-187.78%-242.07%-495.28%-1095.26%--
Pretax Margin
-187.87%-242.07%-495.28%-1095.26%--
Profit Margin
-187.87%-242.07%-495.28%-1095.26%--
FCF Margin
-210.79%-245.32%-337.71%-979.26%--

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
17.4115.5918.8224.54--